Alector (ALEC) Stock: Buy, Sell, or Hold?
ALEC - Alector, Inc. Common Stock
$1.83
-0.04 (-2.14%)
▼
5d:
-4.19%
30d:
-9.41%
90d:
+23.65%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When ALEC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALEC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALEC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALEC is currently trading at $1.83, which is considered oversold relative to its 30-day fair value range of $1.84 to $2.03.
Technical Outlook: Technically, ALEC is in a strong uptrend. Immediate support is located at $1.74, while resistance sits at $2.18.
Market Sentiment: ALEC scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.90 (+113.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALEC is in a strong uptrend. Immediate support is located at $1.74, while resistance sits at $2.18.
Market Sentiment: ALEC scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.90 (+113.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.84 -
$2.03
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (24/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 113.1% below Wall St target ($3.90)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.84 -
$2.03
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.74
Resistance Level
$2.18
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.49
Wall Street Target
$3.90
(+113.1%)
Revenue Growth (YoY)
-57.8%
Earnings Growth (YoY)
-86.3%
Share & Embed Analysis
Last updated: October 22, 2026 5:30 PM ET
Data refreshes hourly during market hours. Next update: 6:30 PM
Data refreshes hourly during market hours. Next update: 6:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALEC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 49 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 70 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 75 BUY |
